Category: Psychedelics

Read More

MIRA says ketamine-based drug beats current pain treatments in study

MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) said its experimental ketamine-based drug outperformed currently available pain treatments in preclinical studies, building on months of research that show why the compound might succeed where other treatments have failed. The drug, known as Ketamir-2, demonstrated up to 112% more effective results than pregabalin (Lyrica) …